Interstitial lung disease is a significant risk factor for lung inflammation

(International Association for the Study of Lung Cancer) Pretreatment interstitial lung disease is a significant risk factor for developing symptomatic and severe radiation pneumonitis in stage I non-small cell lung cancer patients treated with stereotactic body radiation therapy alone.